Teiko.bio

Teiko.bio equips scientific and clinical teams with actionable intelligence at a cellular level. Pairing cutting-edge mass cytometry with a high-dimensional machine learning model, teiko.bio unlocks more information about individual immune characteristics to drive clinical insights.

Proteas Bioanalytics Inc.

From a single drop of blood, Proteas Bioanalytics is able to detect the presence of human diseases at their earliest stage, before the onset of symptoms. Our technologies will also provide objective guidance to implement effective treatment options. Proteas Bioanalytics has also developed advanced technologies for the in-depth analysis and biological understanding of single cells and tissue biopsy specimens that complement and validates our blood-based analysis platform. The field of blood and single-cell proteomics offers a tremendous opportunity to reshape the diagnosis and treatment of almost all diseases. Currently used proteomics technologies do not meet the stringent FDA performance criteria due to the high complexity and heterogeneity of human blood, tissue and cells and their analysis method. The Proteas Bioanalytics proprietary proteomics technology: ▪ includes the analysis of all proteins expressed in blood, cells and tissues during healthy or diseased situations ▪ leverages 30-years of our published methods and overcomes previous limitations ▪ leads to the development of novel protein-based biological signatures with actionable clinical importance ▪ leads to the development of novel proteins markers for monitoring the response to treatment (pharmacology, immunotherapy, nutritional intervention, lifestyle intervention) ➢ We are both a platform and disease-specific biosignature with assay development company ➢ Our core proteomics technology can be partnered across indications to pharma and biotech companies, while our internal biomarker platforms will be developed for high unmet needs in the clinical arena The Proteas Bioanalytics team has extensive industrial, academic, and government experience in research and development, partnering, biology, pharmacology, analytical chemistry, nanotechnology, mathematics and artificial intelligence that will promotes the development of a state-of-the-art and innovative platforms.

Sapropel Organics USA

Distributor of Humuson products, made from Sapropel - a unique and highly stable raw material created by nature. It comes from a freshwater lake sediment formed over 10,000 years in Lithuania, consisting of various nutrients, including humic and fulvic acids. These products are created by biomimetic principles and act faster, more efficiently and more effectively than artificial fertilizers. Our products recreate the natural processes in the soil, reducing the amount of chemical fertilizers needed, increasing plant efficiency and improving harvest quality and quantity. Tested and tried in Europe, Middle East and Africa and now, the United States. Proven track record increasing yields and quality of your crops. Certified Organic by Ecocert, OMRI and CDFA applications pending. Organic fertilizer at conventional pricing! Reach out for your trial.

My Gene Counsel, LLC

My Gene Counsel is the source of accurate, cutting-edge, unbiased genetic information written in language you can understand and use. We will translate the jargon behind the latest breakthrough on the evening news and tell you what it really means for you and your family.

Syntr Health Technologies, Inc.

Late Clinical Stage company using our FDA Cleared system for a variety of surgical indications like breast cancer reconstruction, facial aesthetics, wound care, and orthopedic surgery.